HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 2,233-2,244 of 4,505
Behavioral study icon
CompletedNCT04768335

Auditory Processes and Emotional Perception in Schizophrenia

Official study title

Pilot Study: the Links Between Basic Auditory Processes and High Functioning Cognitive Processes in Schizophrenia (Reality Monitoring and Emotional Perception)

This study has finished and is no longer accepting participants.

In Bron
SchizophreniaBehavioural studyAges 18–65
Countries
France
Sponsor
Hôpital le Vinatier
Other study type icon
CompletedNCT01886417

Auditory Verbal Hallucinations in Schizophrenia

Official study title

Electromyography Study of Lip Muscles During Auditory Verbal Hallucinations Without Subvocalization in Patients With Schizophrenia

This study has finished and is no longer accepting participants.

In Grenoble
SchizophreniaObservational studyAges 18–60
Countries
France
Sponsor
University Hospital, Grenoble
Behavioral study icon
CompletedNCT02716584

Benefits of Physical Exercise in Schizophrenia

Official study title

Physical Exercise Effects on Determinants of Social Integration in Schizophrenia

This study has finished and is no longer accepting participants.

In West Los Angeles
SchizophreniaBehavioural studyAges 40–65
Countries
United States
Sponsor
VA Office of Research and Development (Government agency)
Drug study icon
CompletedNCT03251716

Berberine Treat Metabolic Syndrome in Schizophrenia

Official study title

Berberine in the Treatment of Metabolic Syndrome : an Open Label Clinical Study in Female Schizophrenia Patients

This study has finished and is no longer accepting participants.

In Tianjin
SchizophreniaMedication studyAges 18–60
Countries
China
Sponsor
Tianjin Anding Hospital
Drug study icon
CompletedNCT00535574

Bexarotene Augmentation of Antipsychotic Treatment for Chronic Schizophrenia

Official study title

Bexarotene Augmentation of Antipsychotic Treatment for Chronic Schizophrenia: a 6-week, Randomized, Double-blind Placebo-controlled Trial

This study has finished and is no longer accepting participants.

Multiple locations, including Beersheba
SchizophreniaMedication studyAges 18–60
Countries
Israel
Sponsor
Beersheva Mental Health Center
Drug study icon
CompletedNCT00193713

Bifeprunox in the Treatment of Schizophrenia

Official study title

A Randomized, Double-Blind, Olanzapine-Referenced, Parallel-Group Safety and Efficacy Study of Flexible Doses of Bifeprunox in the Long-term Treatment of Schizpohrenia (Extension of S1543003)

This study has finished and is no longer accepting participants.

Location not clearly listed
SchizophreniaMedication studyAges 18–75
Countries
Sponsor
Solvay Pharmaceuticals
Other study type icon
CompletedNCT00540267

Bone Density in people with Schizophrenia

Official study title

Bone Mineral Density in the Korean Patients With Chronic Schizophrenia With Alcohol Abuse

This study has finished and is no longer accepting participants.

In Busan
SchizophreniaObservational studyAges 18–80
Countries
South Korea
Sponsor
Inje University

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.